Stocks · News reference
Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Accuray (NASDAQ:ARAY) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Fiscal Year 2027 Financial GuidanceAs the Company enters fiscal 2027, management believes Accuray is operating from a position of greater strength than a year ago. The Company expects continued growth in service
Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.10) by 80 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same